Press Centre
PharmaTech Integrates 2025 - Life Science Integrates | Glasgow 18th September 2025
Alcyomics will be in attendance to showcase our unique screening services offering a reliable alternative to animal testing for safety and efficacy of cellular products and compounds.
Read moreAdvanced Therapies Integrates North 2025 – 30th April 2025
Along with other industry leaders we will be attending the Advanced Therapies Integrates North event in Edinburgh this April.
Read moreBIO International Convention 2025 Boston MA – 16th – 19th June 2025
Join Alcyomics at the largest and most comprehensive event for biotechnology leaders from across the globe.
Read morePEGS Boston Summit Protein & Antibody Engineering Summit | May 12-16, 2025 | Boston, MA
Alcyomics will be attending the 21st Annual PEGS Summit in Boston May 2025
Read moreFDA announcement
A landmark announcement from the FDA to phase out animal testing requirement for monoclonal antibodies by replacing with more effective human-relevant methods has now been published.
Read moreAlcyomics® to Transform Drug Discovery for Osteoarthritis Treatment With Unique In Vitro Bio-Printed 3D Tissue Model.
Newcastle upon Tyne, 26 January, 2023. Alcyomics Limited® announces it is seeking partners to participate in validation tests of its unique in vitro 3D bio-printed Osteoarthritis tissue model.
Read more1
2
3
4
Next »
